# Bristol-Myers Squibb Co. (BMY)

> Bristol-Myers Squibb Co. (BMY) trades at $58.34 (-2.05%) as of 7:59:40 PM EST on Nov 19, 2026, -4.55% over the past month. Market cap is $121.75B, with 4.2 days to cover in short interest.

Canonical: https://massive.com/quote/bmy
Data as of: 2026-11-20T00:59:40.831Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$58.34** -1.22 (-2.05%)
At close · 15-minute delayed
NYSE · usd

After hours: **$58.93** +0.59 (+1.01%)
As of 7:59:40 PM EST on Nov 19, 2026 · After hours

## Stock performance

How Bristol-Myers Squibb Co. (BMY) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -2.05% |
| 1W | -6.39% |
| 1M | -4.55% |
| YTD | +8.16% |
| 1Y | +26.14% |
| 52-wk range | $45.52 – $68.64 |

From daily closes through Nov 19, 2026.

## Key statistics

Today's trading snapshot for BMY: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $57.88 – $59.30 |
| Open | $59.19 |
| Prev close | $59.56 |
| Volume | 13.68M |
| Market cap | $121.75B |
| Shares out | 2.04B |

## Valuation and profitability ratios

Valuation and profitability ratios for Bristol-Myers Squibb Co.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 13.12 |
| P/S | 2.48 |
| P/B | 5.45 |
| P/FCF | 10.64 |
| ROE | 41.6% |
| ROA | 10.6% |
| Debt/Equity | 1.93 |
| Div yield | 4.18% |

As of Nov 18, 2026

## Insider trading

[Bristol-Myers Squibb Co. (BMY) insider trading](https://massive.com/quote/bmy/insider-trading.md): open-market Form 4 buys and sells by Bristol-Myers Squibb Co. insiders over the last 12 months.

## 8-K filings

Material corporate events Bristol-Myers Squibb Co. has disclosed to the SEC on Form 8-K.

- Oct 29, 2026 · Investor presentation
  “On October 29, 2026, the Company posted on its website ... a presentation (the "Bristol Myers Presentation") on certain financial and operating initiatives available for viewing during the Company's conference call and webcast announcing its financial results for the third quarter of 2026.”
- Jul 30, 2026 · Investor presentation
  “On July 30, 2026, the Company posted on its website at www.bms.com a presentation (the "Bristol Myers Presentation") on certain financial and operating initiatives available for viewing during the Company's conference call and webcast announcing its financial results for the second quarter of 2026 at 8:15 a.m. Eastern time.”
- May 8, 2026 · Annual meeting results
  “The Annual Meeting of the Company was held on May 5, 2026. Shareholders voted on the matters set forth below. The shareholders elected each of the Company's 11 nominees to serve as directors of the Company until the 2027 Annual Meeting based upon the following votes: \[detailed voting results for all 11 directors\]”
- Apr 30, 2026 · Investor presentation
  “On April 30, 2026, the Company posted on its website at www.bms.com a presentation (the "Bristol Myers Presentation") on certain financial and operating initiatives available for viewing during the Company's conference call and webcast announcing its financial results for the first quarter of 2026.”
- Feb 5, 2026 · Investor presentation
  “On February 5, 2026, the Company posted on its website at www.bms.com a presentation (the "Bristol Myers Presentation") on certain financial and operating initiatives available for viewing during the Company's conference call and webcast announcing its financial results for the fourth quarter of 2025 and full year of 2025.”

## Dividend history and stock splits

Bristol-Myers Squibb Co.'s recent dividend payments and stock splits.

### Dividends

- $0.63 · ex-div Oct 2, 2026
- $0.63 · ex-div Jul 2, 2026
- $0.63 · ex-div Apr 2, 2026
- $0.63 · ex-div Jan 2, 2026

### Splits

No recent splits.

## Similar companies

Public companies in a similar business to Bristol-Myers Squibb Co..

- [MRK](https://massive.com/quote/mrk.md) Merck & Co., Inc. (-3.61%)
- [PFE](https://massive.com/quote/pfe.md) Pfizer Inc. (-1.85%)
- [JNJ](https://massive.com/quote/jnj.md) Johnson & Johnson (-2.04%)
- [ABBV](https://massive.com/quote/abbv.md) ABBVIE INC. (-0.86%)
- [AMGN](https://massive.com/quote/amgn.md) Amgen Inc (-1.14%)
- [LLY](https://massive.com/quote/lly.md) Eli Lilly & Co. (-2.29%)
- [GILD](https://massive.com/quote/gild.md) Gilead Sciences Inc (-1.45%)
- [EXEL](https://massive.com/quote/exel.md) Exelixis Inc (-3.60%)

Daily change in the latest session, 15-minute delayed.

## BMY short interest

How heavily BMY is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 4.2 |
| Short interest | 46.85M |
| Avg volume | 11.06M |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## BMY news

The latest news and headlines about Bristol-Myers Squibb Co. (BMY).

- [Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors](https://www.fool.com/earnings/takeaways/2026/11/18/bristol-myers-squibb-3-key-takeaways-for-long-term-investors/?source=iedfolrf0000001) · The Motley Fool · Nov 18, 2026 · positive sentiment
- [Bristol Myers vs. Merck: Which Big Pharma Stock Is the Better Buy?](https://www.zacks.com/stock/news/3032079/bristol-myers-vs-merck-which-big-pharma-stock-is-the-better-buy?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-3032079) · Zacks Investment Research · Nov 18, 2026 · positive sentiment
- [NSCLC Treatment Landscape Shifts as ESMO 2026 Spotlights MET, KRAS, and TROP2 Advances, Says DelveInsight](https://www.globenewswire.com/news-release/2026/11/18/3406076/0/en/nsclc-treatment-landscape-shifts-as-esmo-2026-spotlights-met-kras-and-trop2-advances-says-delveinsight.html) · GlobeNewswire Inc. · Nov 18, 2026 · positive sentiment
- [Merck Ends Nemtabrutinib Development: What's Next for Its Pipeline?](https://www.zacks.com/stock/news/3031893/merck-ends-nemtabrutinib-development-what-s-next-for-its-pipeline?cid=CS-ZC-FT-analyst_blog|quick_take-3031893) · Zacks Investment Research · Nov 18, 2026 · neutral sentiment
- [Erasca Enters into Clinical Collaboration with Bristol Myers Squibb to Evaluate ERAS-0015 in Clinical Study with Navlimetostat](https://www.globenewswire.com/news-release/2026/11/17/3405323/0/en/erasca-enters-into-clinical-collaboration-with-bristol-myers-squibb-to-evaluate-eras-0015-in-clinical-study-with-navlimetostat.html) · GlobeNewswire Inc. · Nov 17, 2026 · positive sentiment

## About Bristol-Myers Squibb Co.

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

| Measure | Value |
| --- | --- |
| Exchange | NYSE |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32.5K |
| Listed | Jun 23, 1952 |

[Company website](https://www.bms.com)

## FAQ

### What is the Bristol-Myers Squibb Co. (BMY) stock price today?

Bristol-Myers Squibb Co. (BMY) is trading at $58.34 (-2.05% on the day) as of 7:59:40 PM EST on Nov 19, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Bristol-Myers Squibb Co.?

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development.

### What is the short interest in BMY?

As of Oct 30, 2026, BMY has 46.85M shares short and 4.2 days to cover.

### Does Bristol-Myers Squibb Co. (BMY) pay a dividend?

Yes. Bristol-Myers Squibb Co. (BMY)'s most recent dividend was $0.63 per share, with an ex-dividend date of Oct 2, 2026. Full BMY dividend history is available from the Massive API.

### What exchange is BMY listed on?

Bristol-Myers Squibb Co. (BMY) trades on NYSE in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time BMY quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=BMY`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Bristol-Myers Squibb Co. (BMY) insider trading](https://massive.com/quote/bmy/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
